AIMS/PURPOSE: To investigate a nurse-led assessment clinic of new referrals of possible @entity726 . To determine the potential for nurse prescribing. To review the background literature about nurse prescribing. METHODS: Audit of the outcomes of @entity1 attending the nurse-led @entity726 assessment clinic during two defined periods (169 @entity1 ). An audit of all @entity1 started on @entity6839 or latanoprost treatment by a nurse following a protocol. RESULTS: A total of 46 @entity1 were commenced on treatment at the clinic, 31 on @entity6839 , 14 on latanoprost, and one on @entity16495 . Four of these had the treatment stopped at the review clinic in order to reassess the diagnosis. Four @entity1 in the @entity6839 group developed side effects requiring a change in medication, but these could not have been predicted from their past medical history. Nine @entity1 had treatment changed or added to because the intraocular pressure was felt to be inadequately controlled. During the two 3-month audits, a further 11 @entity1 were commenced on treatment for @entity726 at the review clinic. CONCLUSIONS: Initial data from this clinic suggest that nurses possess the diagnostic skills necessary to prescribe for new @entity726 @entity1 . The legal and administrative frame works are developing for more nurses to be able to prescribe. With the newer prostaglandin treatments for @entity726 being available, nurses may usefully and safely be able to prescribe first-line treatments for @entity726 .

Nurse prescribing in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity16495 :: ('MESH:C015620', 'Chemical') :: ['brimonidine'] @entity726 :: ('MESH:D005901', 'Disease') :: ['glaucoma'] @entity6839 :: ('MESH:D013999', 'Chemical') :: ['timolol']
@entity726 :: (MESH:D005901,Disease) :: ['glaucoma']
